BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8678956)

  • 1. Prophylactic surgery for multiple endocrine neoplasia type IIa after genetic diagnosis: is parathyroid transplantation indicated?
    Decker RA; Geiger JD; Cox CE; Mackovjak M; Sarkar M; Peacock ML
    World J Surg; 1996 Sep; 20(7):814-20; discussion 820-1. PubMed ID: 8678956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
    Sanso GE; Domene HM; Garcia R; Pusiol E; de M; Roque M; Ring A; Perinetti H; Elsner B; Iorcansky S; Barontini M
    Cancer; 2002 Jan; 94(2):323-30. PubMed ID: 11900218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B.
    Skinner MA; DeBenedetti MK; Moley JF; Norton JA; Wells SA
    J Pediatr Surg; 1996 Jan; 31(1):177-81; discussion 181-2. PubMed ID: 8632274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic thyroidectomy, based on direct genetic testing, in patients at risk for the multiple endocrine neoplasia type 2 syndromes.
    Wells SA; Skinner MA
    Exp Clin Endocrinol Diabetes; 1998; 106(1):29-34. PubMed ID: 9516056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic testing for familial cancer. Consequences of RET proto-oncogene mutation analysis in multiple endocrine neoplasia, type 2.
    Learoyd DL; Marsh DJ; Richardson AL; Twigg SM; Delbridge L; Robinson BG
    Arch Surg; 1997 Sep; 132(9):1022-5. PubMed ID: 9301617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary hyperparathyroidism in multiple endocrine neoplasia type IIa: retrospective French multicentric study. Groupe d'Etude des Tumeurs á Calcitonine (GETC, French Calcitonin Tumors Study Group), French Association of Endocrine Surgeons.
    Kraimps JL; Denizot A; Carnaille B; Henry JF; Proye C; Bacourt F; Sarfati E; Dupond JL; Maes B; Travagli JP; Boneu A; Roger P; Houdent C; Barbier J; Modigliani E
    World J Surg; 1996 Sep; 20(7):808-12; discussion 812-3. PubMed ID: 8678955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple endocrine neoplasia type iia: report of a family with a study of three generations in qatar.
    Zirie M; Mohammed I; El-Emadi M; Haider A
    Endocr Pract; 2001; 7(1):19-27. PubMed ID: 11250764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A.
    Skinner MA; Moley JA; Dilley WG; Owzar K; Debenedetti MK; Wells SA
    N Engl J Med; 2005 Sep; 353(11):1105-13. PubMed ID: 16162881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of the Parathyroid Glands During Preventive Thyroidectomy in Patients With Multiple Endocrine Neoplasia Type 2.
    Moley JF; Skinner M; Gillanders WE; Lairmore TC; Rowland KJ; Traugott AL; Jin LX; Wells SA
    Ann Surg; 2015 Oct; 262(4):641-6. PubMed ID: 26366543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of multiple endocrine neoplasia type 2A in children: therapeutic results of early thyroidectomy and prognostic value of codon analysis.
    Szinnai G; Meier C; Komminoth P; Zumsteg UW
    Pediatrics; 2003 Feb; 111(2):E132-9. PubMed ID: 12563086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nationwide clinical survey of patients with multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma in Japan.
    Iihara M; Yamashita T; Okamoto T; Kanbe M; Yamazaki K; Egawa S; Yamaguchi K; Obara T
    Jpn J Clin Oncol; 1997 Jun; 27(3):128-34. PubMed ID: 9255265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prophylactic thyroidectomy in children who are carriers of a multiple endocrine neoplasia type 2 mutation: description of 20 cases and recommendations based on the literature].
    de Groot JW; Links TP; Rouwe CW; van der Wal JE; Hofstra RM; Plukker JT
    Ned Tijdschr Geneeskd; 2006 Feb; 150(6):311-8. PubMed ID: 16503023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RET germline mutation in codon 791 in a family representing 3 generations from age 5 to age 70 years: should thyroidectomy be performed?
    Brauer VF; Scholz GH; Neumann S; Lohmann T; Paschke R; Koch CA
    Endocr Pract; 2004; 10(1):5-9. PubMed ID: 15251615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical management of hyperparathyroidism in patients with multiple endocrine neoplasia type 2A.
    Herfarth KK; Bartsch D; Doherty GM; Wells SA; Lairmore TC
    Surgery; 1996 Dec; 120(6):966-73; discussion 973-4. PubMed ID: 8957482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic thyroidectomy in pediatric carriers of multiple endocrine neoplasia type 2A or familial medullary thyroid carcinoma: mutation in C620 is associated with Hirschsprung's disease.
    Bütter A; Gagné J; Al-Jazaeri A; Emran MA; Deal C; St-Vil D
    J Pediatr Surg; 2007 Jan; 42(1):203-6. PubMed ID: 17208566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on the MEN 2A c804 RET mutation: is prophylactic thyroidectomy indicated?
    Frohnauer MK; Decker RA
    Surgery; 2000 Dec; 128(6):1052-7;discussion 1057-8. PubMed ID: 11114642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prophylactic total thyroidectomy in children and adolescents with genetic mutations in the RET-protooncogene].
    Spinelli C; Puccini M; Bertocchini A; Lima M; Pacini F; Miccoli P
    Pediatr Med Chir; 2002; 24(1):53-7. PubMed ID: 11938683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations.
    Learoyd DL; Gosnell J; Elston MS; Saurine TJ; Richardson AL; Delbridge LW; Aglen JV; Robinson BG
    Clin Endocrinol (Oxf); 2005 Dec; 63(6):636-41. PubMed ID: 16343097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Management of multiple endocrine neoplasia syndrome type 2 families in association with rare germline mutations of the RET proto-oncogene].
    Fitze G; Saeger HD; Roesner D; Schackert HK
    Klin Padiatr; 2004; 216(5):270-6. PubMed ID: 15455293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The identification of false positive responses to the pentagastrin stimulation test in RET mutation negative members of MEN 2A families.
    Marsh DJ; McDowall D; Hyland VJ; Andrew SD; Schnitzler M; Gaskin EL; Nevell DF; Diamond T; Delbridge L; Clifton-Bligh P; Robinson BG
    Clin Endocrinol (Oxf); 1996 Feb; 44(2):213-20. PubMed ID: 8849577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.